RIPK1 and acute kidney injury: demonstrated that by preventing IGFBP7/IGF1R‐mediated inflammation and programmed cell death, as well as by decreasing renal necroptosis through the RIPK1/RIPK3/MLKL pathway, genocide XLIX protects against AKI [14].